Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Niemann-Pick Disease Type C1
NCT02124083Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in Niemann-Pick disease type C (NPC), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Apr 2014; status: completed.
02
Drugs
vorinostat
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on NCT02124083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124083.